NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/12/2025
Voltar para busca
Dado oficial do USPTO
RAKUTEN MEDICAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
RAKUTEN MEDICAL
ST13
US500000090981512Classe
35, 41, 42, 44
Pedido
90981512
Registro
8052456
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
66
Atualização mais recente
03/12/2025
Tipo de marca
Verbal
Classes Nice
35, 41, 42, 44
Data de depósito
11/11/2020
Data de registro
02/12/2025
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/12/2025
Última transação
03/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
10/01/2023
Primeiro uso no comércio
10/01/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
SETAGAYA-KU, TOKYO, JP
Examinador
IN,SUNG HYUN
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
RAKUTEN GROUP, INC.
Rakuten, Inc.
Representantes
Anna Kurian Shaw HOGAN LOVELLS US LLP
Classificação técnica
Classes Nice
Classe 35Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Compilation of statistical data relating to medical research for business purposes
Classe 41
Educational servicesproviding training in the field of medicinesmedical devicespharmaceuticalsclinical trials and health care; Teaching and training servicescoursesclasseslessons and seminars in the field of medicinespharmaceuticals and health care; Arrangingconducting and organization of congressesconferencesconventions and symposiums in the field of medicinespharmaceuticals and health care; Educational servicesproviding classesseminarslecturesall in the field of the diagnosis and treatment of cancer; education in the nature of classesseminarstraining in the oncology field
Classe 42
Testing and research on medical treatment methods and techniques; Provision of medical and scientific research information on clinical trials; Research and development in the field of immunology; Testing and research on pharmaceuticals; Medical and pharmacological research services and clinical trials for others; Researchdevelopmentconsultation related thereto in the field of medicine; Providing medical and scientific research information in the field of pharmaceuticals; Pharmaceutical drug development services; Medical laboratories; Design and development of medical technology; Scientificbiological and medical research; Conducting clinical trials for others
Classe 44
Medical services; Medical information; Providing medical information from a web site; Medical testing for diagnostic or treatment purposes; Medical treatment services; Medical care services; Medical analysis services relating to the treatment of persons provided by a medical laboratory; Medical services in the field of oncology; Medical consultation; Medical advisory services; Compilation of medical reportsmedical reporting services; Issuing of medical reportsmedical reporting services; Medical and healthcare clinics; Medical assistance; Healthcare services; Rental of medical machines and apparatus; Consultancy and information services relating to the diagnosticprophylactictherapeutic properties of medical products; Providing information in the field of health caremedical conditionsmedicine and pharmaceuticals; Providing medical information on pharmaceuticals and oncology platforms; Providing medical and patient support information in relation to the treatment of cancer; Counselling servicesmedical counselling for patients diagnosed with cancer; Information services in the field of diagnosing and treating cancer; Providing online information servicesprescription drug information regarding diagnosticprophylactictherapeutic properties; Providing information in the field of medicine; Providing medical information regarding medical conditions and diseases and providing information relating to the health effects of pharmaceuticals; Providing information and content about cancercancer recoverycancer treatmentpost-cancer treatment care and survival via a website; Providing information about cancercancer recoverycancer treatmentpost-cancer treatment care and survival via an online searchable database; Medical diagnostic testing and reporting services; Genetic testing for diagnostic and treatment purposes; Providing healthcare information regarding cancer drugs and cancer treatment; Maintaining personal medical history records and files
Publicações
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
02/12/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/11/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/11/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
27/10/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
23/10/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
28/08/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/08/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
28/08/2025
SNEA
SU-EXAMINER'S AMENDMENT WRITTEN
28/08/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/05/2025
GNRT
NON-FINAL ACTION E-MAILED
14/05/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
14/05/2025
ALIE
ASSIGNED TO LIE
14/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/12/2024
DRRR
DIVISIONAL REQUEST RECEIVED
14/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/11/2024
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
14/11/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/09/2024
GNRT
NON-FINAL ACTION E-MAILED
09/09/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
09/09/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/08/2024
IUAF
USE AMENDMENT FILED
05/08/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/08/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/02/2024
EX5G
SOU EXTENSION 5 GRANTED
21/02/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
21/02/2024
EXT5
SOU EXTENSION 5 FILED
05/02/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/02/2024
DOCK
ASSIGNED TO EXAMINER
26/10/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/08/2023
EX4G
SOU EXTENSION 4 GRANTED
08/08/2023
EXT4
SOU EXTENSION 4 FILED
08/08/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/08/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/01/2023
EX3G
SOU EXTENSION 3 GRANTED
23/01/2023
EXT3
SOU EXTENSION 3 FILED
23/01/2023
EEXT
SOU TEAS EXTENSION RECEIVED
23/01/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/08/2022
EX2G
SOU EXTENSION 2 GRANTED
05/08/2022
EXT2
SOU EXTENSION 2 FILED
05/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/01/2022
EX1G
SOU EXTENSION 1 GRANTED
20/01/2022
EXT1
SOU EXTENSION 1 FILED
20/01/2022
EEXT
SOU TEAS EXTENSION RECEIVED
20/01/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/08/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
20/07/2021
APET
ASSIGNED TO PETITION STAFF
19/07/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
24/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/06/2021
PUBO
PUBLISHED FOR OPPOSITION
15/06/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/05/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/05/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/05/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
23/04/2021
GNSL
LETTER OF SUSPENSION E-MAILED
23/04/2021
CNSL
SUSPENSION LETTER WRITTEN
23/04/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
23/04/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/04/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
23/04/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/04/2021
DOCK
ASSIGNED TO EXAMINER
14/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/01/2021
NWAP
NEW APPLICATION ENTERED
14/11/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RAKUTEN MEDICAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.